101711-90-4

Basic information

• Product Name: (S)-4-benzyl-2-oxazolidinone lithium salt
• CAS NO: 101711-90-4
• Molecular Weight: 183.136
• Mol File: 101711-90-4.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: (S)-4-benzyl-2-oxazolidinone lithium salt(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-benzyl-2-oxazolidinone lithium salt(101711-90-4)
• EPA Substance Registry System: (S)-4-benzyl-2-oxazolidinone lithium salt(101711-90-4)

Safety Data

• Hazardous Substances Data: 101711-90-4(Hazardous Substances Data)

Upstream product

• 90719-32-7 (S)-4-Benzyl-2-oxazolidinone 

Downstream Products

• 111292-87-6 (S)-4-benzyl-3-butyryloxazolidin-2-one 
• 325709-38-4 3-(3(R)-phenyl-4-ene-1-oxopentyl)-4(S)-(benzyl)-2-oxazolidinone 
• 325709-82-8 3-(3(S)-phenyl-4-ene-1-oxopentyl)-4(S)-(benzyl)-2-oxazolidinone 
• 325709-35-1 3-(2(R,S)-isopropyl-4-ene-1-oxopentyl)-4(S)-(benzyl)-2-oxazolidinone 
• 154006-98-1 (4S)-3-<(2E)-3-(4-methoxyphenyl)propenoyl>-4-phenylmethyl-1,3-oxazolidin-2-one 
• 185342-16-9 (S)-4-Benzyl-3-[2-(3-benzyloxy-5-methoxy-phenyl)-acetyl]-oxazolidin-2-one 
• 273753-64-3 1-(4(S)-Benzyl-2-oxo-oxazolidin-3-yl)-hexane-1,5-dione 
• 313467-78-6 (4S)-4-benzyl-3-(3-[1,1'-biphenyl-4-yl]propanoyl)-1,3-oxazolidin-2-one 
• 143868-89-7 3-(1-oxopentyl)-4(S)-(phenylmethyl)-2-oxazolidinone 
• 204711-93-3 4S-benzyl-3-(6-heptenoyl)-oxazolidin-2-one 
• 225377-48-0 3-<1-oxo-3-(2-thiazolyl)propyl>-4(S)-(phenylmethyl)-2-oxazolidinone 
• 192203-73-9 (4S)-3-(3-phenyl-2-propyonyl)-4-benzyloxazolidin-2-one 
• 192203-74-0 (4S)-3-(2-butynoyl)-4-benzyl-1,3-oxazolidin-2-one 
• 1026226-35-6 (2S,3R,4S)-4-Benzo[1,3]dioxol-5-yl-3-((S)-4-benzyl-2-oxo-oxazolidine-3-carbonyl)-2-(2-pyrazol-1-yl-ethyl)-pyrrolidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Syntheses of all the stereoisomers of butanol type 1,7-seco-2,7′-cyclolignane

All the stereoisomers of butanol type 1,7-seco-2,7′-cyclolignane were stereoselectively synthesized by employing (S)- and (R)-Evans' auxiliaries to construct the stereochemistry. (+)- and (-)-Kadangustin J and their diastereomers were also prepared. The optical purity of the synthesized butanol type 1,7-seco-2,7′-cyclolignane was more than 99%ee.

Asymmetric synthesis of (E)-dehydroapratoxin A

An asymmetric approach to key intermediate 17 starting from lactone 7 is described, in which Evan's alkylation and CBS-catalyzed reduction are used for construction of the chiral centers, respectively. Thus, the synthesis of (E)-dehydroapratoxin A 6 could

N-FORMYL HYDROXYLAMINE COMPOUNDS

Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compou